Erich Hunziker
Chairman presso NOVIMMUNE SA
Patrimonio netto: 48 M $ in data 31/03/2024
Profilo
Erich Hunziker è Presidente del Consiglio di sorveglianza di BB Biotech AG, Presidente del Consiglio di sorveglianza di Discoveric AG, Presidente del Consiglio di sorveglianza di discoveric bio alpha AG, Presidente del Consiglio di sorveglianza di discoveric bio beta AG, Presidente del Consiglio di sorveglianza di discoveric marina AG, Presidente del Consiglio di sorveglianza di Entsia International AG, Presidente del Consiglio di sorveglianza di Light Chain Biosciences AG e Presidente del Consiglio di sorveglianza di Novimmune SA. Fa parte del consiglio di amministrazione di EngMab SARL, International Institute for Management Development, Lamkap Bio Alpha AG, LamKap Bio beta AG, LamKap Bio beta AG e Lamkap Bio Gamma AG. Il Dr. Hunziker è stato precedentemente impiegato come Chief Financial & Information Technology Officer di Roche Holding AG, Chief Financial Officer di F. Hoffmann-La Roche Ltd., Chief Executive Officer di Diethelm Keller Holding AG, Deputy Chairman di Holcim Ltd., Chief Financial Officer di Roche Diagnostics GmbH, Chief Financial Officer di Corange Ltd., Vice Chairman di Roche Holdings, Inc. e Chief Financial Officer di Roche Ventures. È stato anche membro del consiglio di amministrazione di Chugai Pharmaceutical Co., Ltd., Genentech, Inc., AB2 Bio SA e Pharmaq Holding AS. Ha ricevuto il suo dottorato al Politecnico Federale Svizzero.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BB BIOTECH AG
1.73% | 31/12/2022 | 957 884 ( 1.73% ) | 48 M $ | 31/03/2024 |
Posizioni attive di Erich Hunziker
| Società | Posizione | Inizio |
|---|---|---|
| NOVIMMUNE SA | Chairman | - |
| Discoveric Bio Gamma AG | Chairman | - |
| discoveric bio beta AG | Chairman | - |
| discoveric bio alpha AG | Chairman | - |
| discoveric marina AG | Chairman | - |
| Lamkap Bio Gamma AG | Chairman | - |
LamKap Bio beta AG
 LamKap Bio beta AG BiotechnologyHealth Technology LamKap Bio beta AG specializes in research and development. It also focuses on licensing and marketing of medical therapies, in particular antibody-based therapies against cancer and diseases of the immune system. The company was founded on December 12, 2017 and is headquartered in Pfäffikon, Switzerland. | Chairman | - |
| Lamkap Bio Alpha AG | Chairman | - |
| Discoveric AG | Chairman | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░ | - |
| ░░░░░ ░░░░░░░ ░░ | ░░░░░░░░ | - |
Precedenti posizioni note di Erich Hunziker
| Società | Posizione | Fine |
|---|---|---|
| ░░ ░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formazione di Erich Hunziker
| Swiss Federal Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BB BIOTECH AG | Finance |
| ROCHE HOLDING AG | Health Technology |
| CHUGAI PHARMACEUTICAL CO., LTD | Health Technology |
| Aziende private | 23 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Corange Ltd.
 Corange Ltd. Pharmaceuticals: GenericHealth Technology Part of Roche Holding AG, Corange Ltd. is a Bermudian company that manufactures orthopedic and diagnostics equipment. The private company is based in Hamilton, Bermuda. Corange was acquired by Roche Holding AG on May 01, 1997 for $10,930.22 million. | Health Technology |
Roche Holdings, Inc.
 Roche Holdings, Inc. Pharmaceuticals: MajorHealth Technology Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Health Technology |
Holcim Ltd. (Switzerland)
 Holcim Ltd. (Switzerland) Construction MaterialsNon-Energy Minerals Holcim Ltd. engages in the provision of building materials. It carries out its operations through the following product lines: Cement, Aggregates, and Other Construction Materials and Services. The Cement line provides wide range of cementations materials and also develops customized blends for special applications. The Aggregates line includes crushed stone, gravel and sand. The Other Construction Materials and Services line comprises ready-mix concrete, concrete products, asphalt, construction and paving, trading, and other products and services. The company was founded on February 15, 1912 and is headquartered in Zurich, Switzerland. | Non-Energy Minerals |
Diethelm Keller Holding AG
 Diethelm Keller Holding AG Miscellaneous Commercial ServicesCommercial Services Diethelm Keller Holding Ltd. holding company with interest in providing brand management, marketing, logistics and travel services. The firm brands include EDAK, Koenig, Turmix, Zyliss, Wetrok, Delta and Gloster. The company is headquartered in Zurich, Switzerland. | Commercial Services |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the private company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
Roche Ventures
 Roche Ventures Investment ManagersFinance Roche Ventures is the venture investment division of the pharmaceutical company F. Hoffmann-La Roche Ltd., which is a subsidiary of Roche Holding AG (SWX:ROG). The group is headquartered in Basel with operations and affiliates worldwide, and is a world leader in pharmaceuticals and diagnostics. The firm was founded in 2002. | Finance |
Novimmune SA
 Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
Pharmaq Holding AS
 Pharmaq Holding AS Financial ConglomeratesFinance Pharmaq Holding AS invests in shares, obligations, real properties, and other participations. The company was founded on February 22, 2013 and is headquartered in Overhalla, Norway. | Finance |
AB2 Bio SA
 AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Health Technology |
EngMab SARL
 EngMab SARL Pharmaceuticals: MajorHealth Technology EngMab SARL operates as a biotechnology company. It focuses on cancer immunotherapy and hematological malignancies and solid tumors. The company was founded by Klaus Strein in 2013 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
LamKap Bio beta AG
LamKap Bio beta AG BiotechnologyHealth Technology LamKap Bio beta AG specializes in research and development. It also focuses on licensing and marketing of medical therapies, in particular antibody-based therapies against cancer and diseases of the immune system. The company was founded on December 12, 2017 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
Berta Holding AG
 Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
| Entsia International AG | |
| Discoveric AG | |
| Lamkap Bio Alpha AG | |
| Lamkap Bio Gamma AG | |
| discoveric marina AG | |
| discoveric bio alpha AG | |
| discoveric bio beta AG | |
| Discoveric Bio Gamma AG | |
| Discoveric Marketplace AG |
- Borsa valori
- Insiders
- Erich Hunziker
